Skip to Navigation Skip to Content Skip to Footer

Microbiology Logo Microbiology & Immunology
Te Tari Moromoroiti me te Ārai Mate

Bacterial energetics

Bacterial energetics as new target space for drug development

Our laboratory is focused on both fundamental and applied aspects of bacterial bioenergetics and translating this work into the development of new drugs targeting energy generation.


Current work is also focused on determining the mode of action of new TB drugs against energetic targets including: bedaquiline, Q203 and SQ109. 

Priority targets include:

F1Fo-ATP synthase

Non-proton translocating NADH dehydrogenase type II 

Succinate dehydrogenase

Cytochrome bd oxidase


Team members 

Dr Yoshio Nakatani, Research

Dr Adam Heikal, Research

Dr Yosuke Shimaki, Assistant Research

Kiel Hards, PhD

Jessica Petri, PhD

Zoe Williams, PhD candidate,

Please enquire to obtain more specific information on these projects: